Paul Averback's Net Worth
$10.3 Million
Who is Paul Averback?
Paul Averback has an estimated net worth of $10.3 Million. This is based on reported shares in NYMOX PHARMACEUTICAL CORP.
SEC CIK
Paul Averback's CIK is 0001569706
Past Insider Trading and Trends
2018 was Paul Averback's most active year for disposing of shares, totalling 2 transactions. Paul Averback's most active month to dispose stocks was the month of September. In 2018 Paul Averback cashed out on 1,787,600 shares for a total of $4,394,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NYMOX PHARMACEUTICAL CORP (NYMXF) Snapshot price: $0.255
CEOPaul Averback owns 23,331,448 units of Restricted common which is worth $5,949,519.24. In the year 2018 Paul Averback filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.43% | -100.00K |
$1.75 | -$175,000.00 | 23.33M |
Oct 26
| |||
Form 4
| -7.23% | -1.69M |
$2.50 | -$4,219,000.00 | 21.64M |
Oct 29
| |||
| No matching records found | |||||||||